Alembic secures USFDA approval for Diltiazem Hydrochloride extended-release capsules
Express Pharma
OCTOBER 20, 2024
The label provides a detailed indication. Diltiazem Hydrochloride Extended-Release Capsules USP in the 120 mg, 180 mg, and 240 mg dosages have an estimated market size of US$ 28.2 million for the twelve months ending June 2024, according to IQVIA. It is also indicated for the management of chronic stable angina.
Let's personalize your content